@xconomy.com 4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com 5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com 5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com 5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@extremetech.com 8 years ago
Scientists find abandoned drug effective against two human viruses
@WIRED 8 years ago
Cofactor is an RNA sequencing company that's turning away from drug discovery for big pharma toward consumer diagnostics.